documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
175 rows where agency_id = "DEA" and document_type = "Proposed Rule" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEA-2026-0133-0001 | DEA | Schedules of Controlled Substances: Placement of 2-Fluorodeschloroketamine in Schedule I (DEA1442) DEA-2026-0133 | Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I | Proposed Rule | 2026-01-20T05:00:00Z | 2026 | 1 | 2026-01-20T05:00:00Z | 2026-01-20T23:36:31Z | 2026-00954 | 0 | 0 | 09000064b916130f | ||
| DEA-2025-0918-0002 | DEA | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) DEA-2025-0918 | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I | Proposed Rule | 2025-12-16T05:00:00Z | 2025 | 12 | 2025-12-16T05:00:00Z | 2026-01-16T04:59:59Z | 2025-12-23T10:00:13Z | 2025-22963 | 0 | 0 | 09000064b90da711 | |
| DEA-2025-0885-0001 | DEA | Schedules of Controlled Substances: Placement of Bromazolam in Schedule I (DEA1420) DEA-2025-0885 | Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I | Proposed Rule | 2025-12-15T05:00:00Z | 2025 | 12 | 2025-12-15T05:00:00Z | 2025-12-15T20:45:21Z | 2025-22763 | 0 | 0 | 09000064b90d3470 | ||
| DEA-2025-0852-0001 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | Schedules of Controlled Substances: Placement of Cumyl-Pegaclone in Schedule I | Proposed Rule | 2025-12-11T05:00:00Z | 2025 | 12 | 2025-12-11T05:00:00Z | 2026-01-13T04:59:59Z | 2025-12-24T10:00:21Z | 2025-22495 | 0 | 0 | 09000064b90c30e5 | |
| DEA-2025-0555-0001 | DEA | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) DEA-2025-0555 | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I | Proposed Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-11-04T04:59:59Z | 2025-11-04T10:00:11Z | 2025-19348 | 0 | 0 | 09000064b8ff06ce | |
| DEA-2025-0557-0001 | DEA | Designation of P2P Methyl Glycidic Acid as a List I Chemical (DEA1395) DEA-2025-0557 | Designation of P2P Methyl Glycidic Acid as a List I Chemical | Proposed Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-11-04T04:59:59Z | 2025-11-04T10:00:11Z | 2025-19384 | 0 | 0 | 09000064b8ff05d4 | |
| DEA-2022-0145-0006 | DEA | Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) DEA-2022-0145 | Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I | Proposed Rule | 2025-07-25T04:00:00Z | 2025 | 7 | 2025-07-25T04:00:00Z | 2025-08-26T03:59:59Z | 2025-08-21T09:01:13Z | 2025-14022 | 0 | 0 | 09000064b8e9caad | |
| DEA-2023-0098-0002 | DEA | Implementation of the Designer Anabolic Steroid Control Act of 2014 (DEA481) DEA-2023-0098 | Schedules of Controlled Substances: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I | Proposed Rule | 2025-06-26T04:00:00Z | 2025 | 6 | 2025-06-26T04:00:00Z | 2025-07-07T20:45:40Z | 2025-11462 | 0 | 0 | 09000064b8e2ed48 | ||
| DEA-2025-0078-0001 | DEA | Three specific fentanyl-related substances (para-bromofentanyl, para-fluoroacetyl fentanyl, and para-methyl acetyl fentanyl) (DEA1484) DEA-2025-0078 | Schedules of Controlled Substances: Placement of Three Specific Fentanyl-Related Substances in Schedule I | Proposed Rule | 2025-06-10T00:00:00Z | 2025 | 6 | 2025-06-10T00:00:00Z | 2025-07-11T03:59:59Z | 2025-07-09T09:00:36Z | 2025-10372 | 0 | 0 | 09000064b8ded104 | |
| DEA-2025-0081-0001 | DEA | Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl] piperidine) in Schedule I (DEA1146) DEA-2025-0081 | Schedules of Controlled Substances: Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I | Proposed Rule | 2025-06-10T00:00:00Z | 2025 | 6 | 2025-06-10T00:00:00Z | 2025-07-11T03:59:59Z | 2025-07-04T09:00:31Z | 2025-10503 | 0 | 0 | 09000064b8ded153 | |
| DEA-2023-0138-0008 | DEA | Designation of Propionyl Chloride as a List I Chemical (DEA1189) DEA-2023-0138 | Designation of Propionyl Chloride as a List I Chemical | Proposed Rule | 2025-06-03T04:00:00Z | 2025 | 6 | 2025-06-03T04:00:00Z | 2025-07-04T03:59:59Z | 2025-07-04T09:00:30Z | 2025-09983 | 0 | 0 | 09000064b8dd3fbb | |
| DEA-2025-0075-0001 | DEA | Placement of 4-Fluoroamphetamine in Schedule I (DEA1180) DEA-2025-0075 | Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I | Proposed Rule | 2025-06-03T04:00:00Z | 2025 | 6 | 2025-06-03T04:00:00Z | 2025-07-04T03:59:59Z | 2025-07-04T09:00:30Z | 2025-09988 | 0 | 0 | 09000064b8dd403e | |
| DEA-2023-0029-35465 | DEA | Telemedicine Prescribing of Controlled Substances (DEA407) DEA-2023-0029 | Special Registrations for Telemedicine and Limited State Telemedicine Registrations | Proposed Rule | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-01-17T05:00:00Z | 2025-03-19T03:59:59Z | 2025-03-20T01:00:13Z | 2025-01099 | 0 | 0 | 09000064868e2e65 | |
| DEA-2024-0144-0001 | DEA | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246) DEA-2024-0144 | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I | Proposed Rule | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2025-01-30T04:59:59Z | 2025-01-02T02:00:54Z | 2024-30359 | 0 | 0 | 0900006486894777 | |
| DEA-2024-0148-0002 | DEA | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457) DEA-2024-0148 | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I | Proposed Rule | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2025-01-30T04:59:59Z | 2025-01-21T14:06:33Z | 2024-30798 | 0 | 0 | 0900006486894772 | |
| DEA-2024-0134-0001 | DEA | Control of Phenethyl Bromide as a List I Chemical (DEA1282) DEA-2024-0134 | Possible Control of Phenethyl Bromide as a List I Chemical | Proposed Rule | 2024-10-28T04:00:00Z | 2024 | 10 | 2024-10-28T04:00:00Z | 2024-11-28T04:59:59Z | 2024-11-27T19:58:55Z | 2024-24616 | 0 | 0 | 09000064867e8844 | |
| DEA-2024-0118-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (DEA1337) DEA-2024-0118 | Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I | Proposed Rule | 2024-09-17T04:00:00Z | 2024 | 9 | 2024-09-17T04:00:00Z | 2024-09-17T20:04:16Z | 2024-21058 | 0 | 0 | 090000648672f856 | ||
| DEA-2024-0059-42928 | DEA | Schedules of Controlled Substances: Rescheduling of Marijuana DEA-2024-0059 | Schedules of Controlled Substances: Rescheduling of Marijuana | Proposed Rule | 2024-08-29T04:00:00Z | 2024 | 8 | 2024-08-29T04:00:00Z | 2024-09-03T22:48:28Z | 2024-19370 | 0 | 0 | 09000064866b30d2 | ||
| DEA-2023-0168-0156 | DEA | Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156) DEA-2023-0168 | Hearings, Meetings, Proceedings, etc.: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I; Stay | Proposed Rule | 2024-06-07T04:00:00Z | 2024 | 6 | 2024-06-07T04:00:00Z | 2024-06-07T16:05:43Z | 2024-12504 | 0 | 0 | 090000648659daf8 | ||
| DEA-2024-0059-0001 | DEA | Schedules of Controlled Substances: Rescheduling of Marijuana DEA-2024-0059 | Schedules of Controlled Substances: Rescheduling of Marijuana | Proposed Rule | 2024-05-21T04:00:00Z | 2024 | 5 | 2024-05-21T04:00:00Z | 2024-07-23T03:59:59Z | 2024-12-21T02:00:50Z | 2024-11137 | 0 | 0 | 0900006486575c28 | |
| DEA-2021-0031-0007 | DEA | Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I DEA-2021-0031 | Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I | Proposed Rule | 2024-04-11T04:00:00Z | 2024 | 4 | 2024-04-11T04:00:00Z | 2024-05-14T03:59:59Z | 2024-05-03T19:54:22Z | 2024-07694 | 0 | 0 | 09000064864cd92b | |
| DEA-2023-0168-0155 | DEA | Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156) DEA-2023-0168 | Hearings, Meetings, Proceedings, etc.: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I | Proposed Rule | 2024-04-09T04:00:00Z | 2024 | 4 | 2024-04-09T04:00:00Z | 2024-06-07T16:06:39Z | 2024-07473 | 0 | 0 | 09000064864c2af7 | ||
| DEA-2023-0148-0026 | DEA | Destruction Alternatives to Incineration (DEA1144) DEA-2023-0148 | Controlled Substance Destruction Alternatives to Incineration - Extension of Comment Period | Proposed Rule | 2024-01-03T05:00:00Z | 2024 | 1 | 2024-01-03T05:00:00Z | 2024-04-02T03:59:59Z | 2024-04-02T01:04:01Z | 2023-28964 | 0 | 0 | 0900006486374cf2 | |
| DEA-2023-0168-0001 | DEA | Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156) DEA-2023-0168 | Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I | Proposed Rule | 2023-12-13T05:00:00Z | 2023 | 12 | 2023-12-13T05:00:00Z | 2024-01-13T04:59:59Z | 2024-01-13T20:44:04Z | 2023-27289 | 0 | 0 | 09000064863304b8 | |
| DEA-2023-0148-0001 | DEA | Destruction Alternatives to Incineration (DEA1144) DEA-2023-0148 | Controlled Substance Destruction Alternatives to Incineration | Proposed Rule | 2023-10-31T04:00:00Z | 2023 | 10 | 2023-10-31T04:00:00Z | 2024-04-02T03:59:59Z | 2024-04-10T01:00:33Z | 2023-23984 | 0 | 0 | 090000648619fc8d | |
| DEA-2023-0147-0001 | DEA | Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I (DEA1143) DEA-2023-0147 | Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I | Proposed Rule | 2023-10-25T04:00:00Z | 2023 | 10 | 2023-10-25T04:00:00Z | 2023-10-25T21:34:00Z | 2023-23379 | 0 | 0 | 0900006486134ef2 | ||
| DEA-2023-0138-0001 | DEA | Designation of Propionyl Chloride as a List I Chemical (DEA1189) DEA-2023-0138 | Propionyl Chloride | Proposed Rule | 2023-10-12T04:00:00Z | 2023 | 10 | 2023-10-12T04:00:00Z | 2023-11-14T04:59:59Z | 2023-11-08T02:00:50Z | 2023-22570 | 0 | 0 | 09000064860b9810 | |
| DEA-2023-0129-0001 | DEA | Placement of Ethylphenidate in Schedule I (DEA1142) DEA-2023-0129 | Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I | Proposed Rule | 2023-09-22T04:00:00Z | 2023 | 9 | 2023-09-22T04:00:00Z | 2023-11-22T04:59:59Z | 2023-11-22T02:03:41Z | 2023-20439 | 0 | 0 | 0900006485fe5771 | |
| DEA-2023-0059-0001 | DEA | Designation as List I Chemicals: Halides of 4-Anilinopiperidine (DEA1098) DEA-2023-0059 | Designation as List I Chemicals: Halides of 4-Anilinopiperidine | Proposed Rule | 2023-04-14T04:00:00Z | 2023 | 4 | 2023-04-14T04:00:00Z | 2023-05-16T03:59:59Z | 2023-04-14T12:24:33Z | 2023-07454 | 0 | 0 | 0900006485948d50 | |
| DEA-2023-0057-0001 | DEA | Definition of ‘‘Cannabimimetic Agents’’ and Assignment of an Administration Controlled Substances Code Number for All ‘‘Cannabimimetic Agents’’ (DEA368) DEA-2023-0057 | Definition of Cannabimimetic Agents and Assignment of an Administration Controlled Substances Code Number for all Cannabimimetic Agents | Proposed Rule | 2023-04-13T04:00:00Z | 2023 | 4 | 2023-04-13T04:00:00Z | 2023-05-16T03:59:59Z | 2023-04-20T01:01:08Z | 2023-07578 | 0 | 0 | 0900006485940732 | |
| DEA-2023-0058-0001 | DEA | Placement of Nine Specific Fentanyl Related Substances in Schedule I (DEA1036) DEA-2023-0058 | Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in Schedule I | Proposed Rule | 2023-04-13T04:00:00Z | 2023 | 4 | 2023-04-13T04:00:00Z | 2023-05-16T03:59:59Z | 2023-05-16T01:00:59Z | 2023-07576 | 0 | 0 | 0900006485941111 | |
| DEA-2023-0049-0001 | DEA | Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I (DEA1006) DEA-2023-0049 | Schedules of Controlled Substances: Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I | Proposed Rule | 2023-04-04T04:00:00Z | 2023 | 4 | 2023-04-04T04:00:00Z | 2023-04-04T15:48:01Z | 2023-06893 | 0 | 0 | 09000064858d7f29 | ||
| DEA-2023-0029-0001 | DEA | Telemedicine Prescribing of Controlled Substances (DEA407) DEA-2023-0029 | Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation | Proposed Rule | 2023-03-01T05:00:00Z | 2023 | 3 | 2023-03-01T05:00:00Z | 2023-04-01T03:59:59Z | 2023-04-25T01:00:34Z | 2023-04248 | 0 | 0 | 0900006485732548 | |
| DEA-2023-0028-0001 | DEA | Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948) DEA-2023-0028 | Expansion of Induction of Buprenorphine via Telemedicine Encounter | Proposed Rule | 2023-03-01T05:00:00Z | 2023 | 3 | 2023-03-01T05:00:00Z | 2023-04-01T03:59:59Z | 2023-04-01T23:39:12Z | 2023-04217 | 0 | 0 | 09000064857323db | |
| DEA-2023-0016-0001 | DEA | Controlled Substances Ordering System Modernization (DEA732) DEA-2023-0016 | Controlled Substances Ordering System Modernization | Proposed Rule | 2023-02-02T05:00:00Z | 2023 | 2 | 2023-02-02T05:00:00Z | 2023-04-04T03:59:59Z | 2023-04-05T01:01:13Z | 2023-01804 | 0 | 0 | 090000648562c18e | |
| DEA-2022-0145-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) DEA-2022-0145 | Schedule of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I | Proposed Rule | 2022-12-23T05:00:00Z | 2022 | 12 | 2022-12-23T05:00:00Z | 2022-12-23T12:54:22Z | 2022-27278 | 0 | 0 | 0900006485550cf4 | ||
| DEA-2022-0102-0001 | DEA | Designation of 4-Piperidone as a List I Chemical (DEA951) DEA-2022-0102 | Designation of 4-Piperidone as a List I Chemical | Proposed Rule | 2022-09-22T04:00:00Z | 2022 | 9 | 2022-09-22T04:00:00Z | 2022-10-25T03:59:59Z | 2022-10-20T01:01:07Z | 2022-19974 | 0 | 0 | 090000648534f58b | |
| DEA-2022-0026-0101 | DEA | Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I DEA-2022-0026 | Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I; Withdrawal | Proposed Rule | 2022-08-29T04:00:00Z | 2022 | 8 | 2022-08-29T04:00:00Z | 2022-08-29T12:38:14Z | 2022-18729 | 0 | 0 | 09000064852853f2 | ||
| DEA-2022-0001-0591 | DEA | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I DEA-2022-0001 | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Withdrawal and Notice of Hearing | Proposed Rule | 2022-07-27T04:00:00Z | 2022 | 7 | 2022-07-27T04:00:00Z | 2022-07-27T12:21:18Z | 2022-16102 | 0 | 0 | 09000064851ecfe2 | ||
| DEA-2022-0068-0001 | DEA | Schedules of Controlled Substances: Removal of Fenfluramine From Control DEA-2022-0068 | Schedules of Controlled Substances: Removal of Fenfluramine From Control | Proposed Rule | 2022-07-19T04:00:00Z | 2022 | 7 | 2022-07-19T04:00:00Z | 2022-08-19T03:59:59Z | 2022-07-28T01:00:56Z | 2022-15335 | 0 | 0 | 09000064851d1a59 | |
| DEA-2022-0058-0001 | DEA | Providing CS to Ocean Vessels, Aircraft, and Other Entities DEA-2022-0058 | Providing Controlled Substances to Ocean Vessels, Aircraft, and Other Entities | Proposed Rule | 2022-07-18T04:00:00Z | 2022 | 7 | 2022-07-18T04:00:00Z | 2022-09-17T03:59:59Z | 2022-09-17T01:01:02Z | 2022-15265 | 0 | 0 | 09000064851cf62e | |
| DEA-2022-0001-0590 | DEA | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I DEA-2022-0001 | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I | Proposed Rule | 2022-07-06T04:00:00Z | 2022 | 7 | 2022-07-06T04:00:00Z | 2022-07-07T13:59:19Z | 2022-14372 | 0 | 0 | 09000064851b25a1 | ||
| DEA-2022-0027-0001 | DEA | Schedules of Controlled Substances: Exempted Prescription Products - Butalbital products DEA-2022-0027 | Schedules of Controlled Substances: Exempted Prescription Products | Proposed Rule | 2022-04-12T04:00:00Z | 2022 | 4 | 2022-04-12T04:00:00Z | 2022-05-13T03:59:59Z | 2022-05-13T01:00:46Z | 2022-07572 | 0 | 0 | 090000648500fc8e | |
| DEA-2022-0026-0001 | DEA | Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I DEA-2022-0026 | Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I | Proposed Rule | 2022-04-11T04:00:00Z | 2022 | 4 | 2022-04-11T04:00:00Z | 2022-06-11T03:59:59Z | 2022-06-12T00:21:41Z | 2022-07648 | 0 | 0 | 090000648500addc | |
| DEA-2022-0001-0001 | DEA | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I DEA-2022-0001 | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I | Proposed Rule | 2022-01-14T05:00:00Z | 2022 | 1 | 2022-01-14T05:00:00Z | 2022-02-15T04:59:59Z | 2022-02-16T02:00:43Z | 2022-00713 | 0 | 0 | 0900006484f1fcdd | |
| DEA-2021-0030-0001 | DEA | Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I DEA-2021-0030 | Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I | Proposed Rule | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T05:00:00Z | 2022-02-08T04:59:59Z | 2021-12-11T02:00:42Z | 2021-26293 | 0 | 0 | 0900006484ea7915 | |
| DEA-2021-0031-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I DEA-2021-0031 | Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I | Proposed Rule | 2021-12-07T05:00:00Z | 2021 | 12 | 2021-12-07T05:00:00Z | 2021-12-08T16:07:57Z | 2021-26263 | 0 | 0 | 0900006484ea7b00 | ||
| DEA-2021-0026-0001 | DEA | Transfer of Electronic Prescriptions for Controlled Substances for Initial Filling DEA-2021-0026 | Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances between Pharmacies for Initial Filling | Proposed Rule | 2021-11-19T05:00:00Z | 2021 | 11 | 2021-11-19T05:00:00Z | 2022-01-19T04:59:59Z | 2022-01-20T02:00:23Z | 2021-24981 | 0 | 0 | 0900006484e65ef0 | |
| DEA-2021-0027-0001 | DEA | Regulation of Telepharmacy Practice DEA-2021-0027 | Regulation of Telepharmacy Practice | Proposed Rule | 2021-11-17T05:00:00Z | 2021 | 11 | 2021-11-17T05:00:00Z | 2022-01-19T04:59:59Z | 2022-01-20T02:00:23Z | 2021-24948 | 0 | 0 | 0900006484e56f76 | |
| DEA-2021-0025-0001 | DEA | Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control DEA-2021-0025 | Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control | Proposed Rule | 2021-11-04T04:00:00Z | 2021 | 11 | 2021-11-04T04:00:00Z | 2021-12-07T04:59:59Z | 2021-11-24T02:02:38Z | 2021-23852 | 0 | 0 | 0900006484e17e7d | |
| DEA-2021-0013-0001 | DEA | Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I DEA-2021-0013 | Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I | Proposed Rule | 2021-09-02T04:00:00Z | 2021 | 9 | 2021-09-02T04:00:00Z | 2021-10-05T03:59:59Z | 2021-10-06T01:00:36Z | 2021-18843 | 0 | 0 | 0900006484d43832 | |
| DEA-2021-0012-0001 | DEA | Schedules of Controlled Substances: Placement of Mesocarb in Schedule I DEA-2021-0012 | Schedules of Controlled Substances: Placement of Mesocarb in Schedule I | Proposed Rule | 2021-08-11T04:00:00Z | 2021 | 8 | 2021-08-11T04:00:00Z | 2021-10-13T03:59:59Z | 2021-10-14T01:00:34Z | 2021-16489 | 0 | 0 | 0900006484c42141 | |
| DEA-2021-0011-0001 | DEA | Schedules of Controlled Substances: Placement of Amineptine in Schedule I DEA-2021-0011 | Schedules of Controlled Substances: Placement of Amineptine in Schedule I | Proposed Rule | 2021-07-22T04:00:00Z | 2021 | 7 | 2021-07-22T04:00:00Z | 2021-09-21T03:59:59Z | 2021-08-09T01:00:27Z | 2021-15331 | 0 | 0 | 0900006484c078c2 | |
| DEA-2019-0004-0006 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I DEA-2019-0004 | Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4′-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4′-Chloro-alpha-pyrrolidinovalerophenone in Schedule I | Proposed Rule | 2021-07-16T04:00:00Z | 2021 | 7 | 2021-07-16T04:00:00Z | 2021-08-17T03:59:59Z | 2021-08-18T13:24:48Z | 2021-15114 | 0 | 0 | 0900006484bfbc10 | |
| DEA-2021-0009-0001 | DEA | MAPA - Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine DEA-2021-0009 | Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine | Proposed Rule | 2021-03-30T04:00:00Z | 2021 | 3 | 2021-03-30T04:00:00Z | 2021-06-02T03:59:59Z | 2021-05-11T16:48:13Z | 2021-05346 | 0 | 0 | 0900006484a875c3 | |
| DEA-2019-0002-0005 | DEA | Schedules of Controlled Substances: Placement of 5F-EDMBPINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I DEA-2019-0002 | Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 in Schedule I | Proposed Rule | 2021-03-30T04:00:00Z | 2021 | 3 | 2021-03-30T04:00:00Z | 2021-04-30T03:59:59Z | 2021-04-01T13:19:22Z | 2021-06553 | 0 | 0 | 0900006484a8761d | |
| DEA-2021-0007-0001 | DEA | Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I DEA-2021-0007 | Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I | Proposed Rule | 2021-03-18T04:00:00Z | 2021 | 3 | 2021-03-18T04:00:00Z | 2021-04-20T03:59:59Z | 2021-04-20T01:00:28Z | 2021-05589 | 0 | 0 | 0900006484a6ff9d | |
| DEA-2021-0006-0001 | DEA | Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances into Schedule I DEA-2021-0006 | Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I | Proposed Rule | 2021-03-03T05:00:00Z | 2021 | 3 | 2021-03-03T05:00:00Z | 2021-04-03T03:59:59Z | 2021-04-02T01:00:56Z | 2021-04214 | 0 | 0 | 0900006484a5c7c4 | |
| DEA-2021-0003-0032 | DEA | Suspicious Orders of Controlled Substances DEA-2021-0003 | Suspicious Orders of Controlled Substances | Proposed Rule | 2021-02-25T05:00:00Z | 2021 | 2 | 2021-02-25T05:00:00Z | 2021-03-30T03:59:59Z | 2021-03-30T01:00:21Z | 2021-03361 | 0 | 0 | 0900006484a4d934 | |
| DEA-2021-0005-0001 | DEA | Amending Regulations to Require Online Submission of Applications for and Renewals of DEA Registration DEA-2021-0005 | Amending Regulations To Require Online Submission of Applications for and Renewals of Registration | Proposed Rule | 2021-01-07T05:00:00Z | 2021 | 1 | 2021-01-07T05:00:00Z | 2021-03-09T04:59:59Z | 2021-03-09T02:00:26Z | 2020-28532 | 0 | 0 | 09000064849e5644 | |
| DEA-2021-0001-0001 | DEA | Designation of APAA, PMK glycidate and PMK glycidic acid as List I chemicals DEA-2021-0001 | Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals | Proposed Rule | 2020-12-21T05:00:00Z | 2020 | 12 | 2020-12-21T05:00:00Z | 2021-02-20T04:59:59Z | 2021-02-25T13:50:56Z | 2020-26813 | 0 | 0 | 09000064849aefe0 | |
| DEA-2021-0004-0001 | DEA | Schedules of Controlled Substances: Removal of Samidorphan from Control DEA-2021-0004 | Schedules of Controlled Substances: Removal of Samidorphan From Control | Proposed Rule | 2020-12-10T05:00:00Z | 2020 | 12 | 2020-12-10T05:00:00Z | 2021-01-12T04:59:59Z | 2021-01-12T02:00:35Z | 2020-26812 | 0 | 0 | 090000648499556e | |
| DEA-2020-0035-0001 | DEA | Partial Filling of Prescriptions for Schedule II Controlled Substances DEA-2020-0035 | Partial Filling of Prescriptions for Schedule II Controlled Substances | Proposed Rule | 2020-12-04T05:00:00Z | 2020 | 12 | 2020-12-04T05:00:00Z | 2021-02-03T04:59:59Z | 2021-02-03T02:00:28Z | 2020-26291 | 0 | 0 | 0900006484985b6b | |
| DEA-2020-0038-0001 | DEA | Schedules of Controlled Substances: Placement of Brorphine in Schedule I DEA-2020-0038 | Schedules of Controlled Substances: Temporary Placement of Brorphine in Schedule I | Proposed Rule | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T05:00:00Z | 2020-12-23T16:19:53Z | 2020-26301 | 0 | 0 | 090000648498412a | ||
| DEA-2021-0003-0001 | DEA | Suspicious Orders of Controlled Substances DEA-2021-0003 | Suspicious Orders of Controlled Substances | Proposed Rule | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T05:00:00Z | 2021-01-05T04:59:59Z | 2021-02-25T16:35:27Z | 2020-21302 | 0 | 0 | 0900006484945a99 | |
| DEA-2020-0029-0001 | DEA | Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017 DEA-2020-0029 | Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017 | Proposed Rule | 2020-10-05T04:00:00Z | 2020 | 10 | 2020-10-05T04:00:00Z | 2020-12-05T04:59:59Z | 2020-12-06T02:00:55Z | 2020-21675 | 0 | 0 | 09000064848ce421 | |
| DEA-2020-0027-0001 | DEA | Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration DEA-2020-0027 | Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration | Proposed Rule | 2020-09-30T04:00:00Z | 2020 | 9 | 2020-09-30T04:00:00Z | 2020-12-01T04:59:59Z | 2020-12-01T02:02:00Z | 2020-19309 | 0 | 0 | 09000064848a25f0 | |
| DEA-2020-0025-0001 | DEA | Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I DEA-2020-0025 | Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I | Proposed Rule | 2020-08-27T04:00:00Z | 2020 | 8 | 2020-08-27T04:00:00Z | 2020-09-29T03:59:59Z | 2020-09-28T01:01:08Z | 2020-19007 | 0 | 0 | 0900006484823d52 | |
| DEA-2020-0022-0001 | DEA | Reporting of Theft or Significant Loss of Controlled Substances DEA-2020-0022 | Reporting of Theft or Significant Loss of Controlled Substances | Proposed Rule | 2020-07-29T04:00:00Z | 2020 | 7 | 2020-07-29T04:00:00Z | 2020-09-29T03:59:59Z | 2020-09-28T01:01:01Z | 2020-15635 | 0 | 0 | 09000064847b3625 | |
| DEA-2020-0020-0001 | DEA | Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I DEA-2020-0020 | Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I | Proposed Rule | 2020-07-13T04:00:00Z | 2020 | 7 | 2020-07-13T04:00:00Z | 2020-08-13T03:59:59Z | 2020-08-13T01:01:57Z | 2020-14901 | 0 | 0 | 0900006484745b40 | |
| DEA-2020-0017-0001 | DEA | Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I DEA-2020-0017 | Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I | Proposed Rule | 2020-06-18T04:00:00Z | 2020 | 6 | 2020-06-18T04:00:00Z | 2020-06-19T13:24:57Z | 2020-12304 | 0 | 0 | 09000064846f8a81 | ||
| DEA-2020-0016-0001 | DEA | Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I DEA-2020-0016 | Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I | Proposed Rule | 2020-05-15T04:00:00Z | 2020 | 5 | 2020-05-15T04:00:00Z | 2020-06-16T03:59:59Z | 2020-05-26T16:52:37Z | 2020-09599 | 0 | 0 | 090000648460372c | |
| DEA-2020-0015-0001 | DEA | Schedules of Controlled Substances: Placement of Zipeprol in Schedule I DEA-2020-0015 | Schedules of Controlled Substances: Placement of Zipeprol in Schedule I | Proposed Rule | 2020-05-14T04:00:00Z | 2020 | 5 | 2020-05-14T04:00:00Z | 2020-07-14T03:59:59Z | 2020-07-14T01:01:18Z | 2020-09592 | 0 | 0 | 09000064845f501a | |
| DEA-2020-0009-0001 | DEA | Schedules of Controlled Substances: Placement of 4,4'-DMAR in Schedule I DEA-2020-0009 | Schedules of Controlled Substances: Placement of 4,4′-DMAR in Schedule I | Proposed Rule | 2020-04-07T04:00:00Z | 2020 | 4 | 2020-04-07T04:00:00Z | 2020-06-09T03:59:59Z | 2020-10-19T14:31:29Z | 2020-07095 | 0 | 0 | 090000648448e827 | |
| DEA-2020-0008-0001 | DEA | Controls To Enhance the Cultivation of Marihuana for Research in the United States DEA-2020-0008 | Controls To Enhance the Cultivation of Marihuana for Research in the United States | Proposed Rule | 2020-03-23T04:00:00Z | 2020 | 3 | 2020-03-23T04:00:00Z | 2020-05-23T03:59:59Z | 2020-06-05T01:02:20Z | 2020-05796 | 0 | 0 | 090000648445f2a9 | |
| DEA-2020-0007-0001 | DEA | Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants DEA-2020-0007 | Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants | Proposed Rule | 2020-03-16T04:00:00Z | 2020 | 3 | 2020-03-16T04:00:00Z | 2020-05-16T03:59:59Z | 2020-05-16T01:01:44Z | 2020-05159 | 0 | 0 | 0900006484447dc2 | |
| DEA-2020-0005-0001 | DEA | Registration Requirements for Narcotic Treatment Programs with Mobile Components DEA-2020-0005 | Registration Requirements for Narcotic Treatment Programs with Mobile Components | Proposed Rule | 2020-02-26T05:00:00Z | 2020 | 2 | 2020-02-26T05:00:00Z | 2020-04-28T03:59:59Z | 2020-04-29T01:00:40Z | 2020-03627 | 0 | 0 | 09000064843b4e82 | |
| DEA-2020-0002-0001 | DEA | Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 | Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I | Proposed Rule | 2020-01-30T05:00:00Z | 2020 | 1 | 2020-01-30T05:00:00Z | 2020-03-03T04:59:59Z | 2020-03-03T02:02:48Z | 2020-01681 | 0 | 0 | 090000648430aa75 | |
| DEA-2017-0010-0005 | DEA | Schedules of Controlled Substances: Temporary Placement of FUB-AMB Into Schedule I DEA-2017-0010 | Schedules of Controlled Substances: Placement of FUB-AMB in Schedule I | Proposed Rule | 2019-10-30T04:00:00Z | 2019 | 10 | 2019-10-30T04:00:00Z | 2019-11-30T04:59:59Z | 2019-11-28T02:03:10Z | 2019-23626 | 0 | 0 | 0900006484109366 | |
| DEA-2019-0013-0001 | DEA | Management of Quotas for Controlled Substances and List I Chemicals DEA-2019-0013 | Management of Quotas for Controlled Substances and List I Chemicals | Proposed Rule | 2019-10-23T04:00:00Z | 2019 | 10 | 2019-10-23T04:00:00Z | 2019-12-24T04:59:59Z | 2019-12-25T02:02:14Z | 2019-21989 | 0 | 0 | 09000064840ec847 | |
| DEA-2019-0012-0001 | DEA | Schedules of Controlled Substances: Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as Schedule II DEA-2019-0012 | Schedules of Controlled Substances: Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as Schedule II | Proposed Rule | 2019-09-17T04:00:00Z | 2019 | 9 | 2019-09-17T04:00:00Z | 2019-11-19T04:59:59Z | 2019-11-20T02:02:04Z | 2019-19786 | 0 | 0 | 0900006483f86082 | |
| DEA-2019-0011-0001 | DEA | Schedules of Controlled Substances: Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals DEA-2019-0011 | Schedules of Controlled Substances: Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals | Proposed Rule | 2019-09-13T04:00:00Z | 2019 | 9 | 2019-09-13T04:00:00Z | 2019-11-13T04:59:59Z | 2019-11-13T02:04:07Z | 2019-19787 | 0 | 0 | 0900006483f545ad | |
| DEA-2019-0007-0001 | DEA | Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control DEA-2019-0007 | Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control | Proposed Rule | 2019-08-21T04:00:00Z | 2019 | 8 | 2019-08-21T04:00:00Z | 2019-09-21T03:59:59Z | 2021-03-14T09:28:20Z | 2019-17630 | 0 | 0 | 0900006483e7ef77 | |
| DEA-2019-0004-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I DEA-2019-0004 | Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I | Proposed Rule | 2019-05-01T04:00:00Z | 2019 | 5 | 2019-05-16T15:23:10Z | 2019-08704 | 0 | 0 | 0900006483c223a6 | |||
| DEA-2016-0020-0008 | DEA | Schedules of Controlled Substances: Temporary Placement of six synthetic cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I DEA-2016-0020 | Schedules of Controlled Substances: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I | Proposed Rule | 2019-04-08T04:00:00Z | 2019 | 4 | 2019-04-08T04:00:00Z | 2019-05-09T03:59:59Z | 2019-05-09T01:01:30Z | 2019-06853 | 0 | 0 | 0900006483b716a9 | |
| DEA-2019-0001-0001 | DEA | New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222) DEA-2019-0001 | New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances | Proposed Rule | 2019-02-21T05:00:00Z | 2019 | 2 | 2019-02-21T05:00:00Z | 2019-04-23T03:59:59Z | 2019-04-23T01:01:00Z | 2019-02875 | 0 | 0 | 0900006483a94210 | |
| DEA-2019-0002-0001 | DEA | Schedules of Controlled Substances: Placement of 5F-EDMBPINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I DEA-2019-0002 | Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I | Proposed Rule | 2018-12-28T05:00:00Z | 2018 | 12 | 2018-12-28T05:00:00Z | 2019-04-08T13:18:54Z | 2018-28110 | 0 | 0 | 09000064839cbf72 | ||
| DEA-2018-0011-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I DEA-2018-0011 | Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I | Proposed Rule | 2018-06-13T04:00:00Z | 2018 | 6 | 2018-09-28T13:47:25Z | 2018-12669 | 0 | 0 | 09000064834046ca | |||
| DEA-2018-0010-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA into Schedule I DEA-2018-0010 | Schedules of Controlled Substances: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA into Schedule I | Proposed Rule | 2018-05-30T04:00:00Z | 2018 | 5 | 2018-05-30T12:36:32Z | 2018-11531 | 0 | 0 | 090000648330d3ac | |||
| DEA-2018-0009-0001 | DEA | Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I DEA-2018-0009 | Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I | Proposed Rule | 2018-05-10T04:00:00Z | 2018 | 5 | 2018-05-10T04:00:00Z | 2018-06-12T03:59:59Z | 2018-06-13T01:05:58Z | 2018-10008 | 0 | 0 | 09000064832540d8 | |
| DEA-2018-0005-0001 | DEA | Controlled Substances Quotas DEA-2018-0005 | Controlled Substances Quotas | Proposed Rule | 2018-04-19T04:00:00Z | 2018 | 4 | 2018-04-19T04:00:00Z | 2018-05-05T03:59:59Z | 2018-05-08T01:01:01Z | 2018-08111 | 0 | 0 | 09000064831895a3 | |
| DEA-2016-0003-0003 | DEA | Temporary Placement of the Synthetic Cannabinoid MAB-CHMINACA into Schedule I DEA-2016-0003 | Schedules of Controlled Substances: Placement of MAB-CHMINACA into Schedule I | Proposed Rule | 2018-01-30T05:00:00Z | 2018 | 1 | 2018-01-30T05:00:00Z | 2018-03-02T04:59:59Z | 2018-03-02T02:02:45Z | 2018-01747 | 0 | 0 | 0900006482e7c993 | |
| DEA-2018-0001-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I DEA-2018-0001 | Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I | Proposed Rule | 2017-12-29T05:00:00Z | 2017 | 12 | 2017-12-29T05:00:00Z | 2018-01-05T13:28:52Z | 2017-28114 | 0 | 0 | 0900006482d831c7 | ||
| DEA-2017-0016-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of Seven Fentanyl-related Substances in Schedule I DEA-2017-0016 | Schedules of Controlled Substances: Temporary Placement of Seven Fentanyl-related Substances in Schedule I | Proposed Rule | 2017-12-13T05:00:00Z | 2017 | 12 | 2017-12-19T14:27:41Z | 2017-26854 | 0 | 0 | 0900006482d01f40 | |||
| DEA-2017-0013-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of Cyclopropyl Fentanyl into Schedule I DEA-2017-0013 | Schedules of Controlled Substances: Temporary Placement of Cyclopropyl Fentanyl into Schedule I | Proposed Rule | 2017-11-21T05:00:00Z | 2017 | 11 | 2017-11-22T14:39:02Z | 2017-25077 | 0 | 0 | 0900006482c98388 | |||
| DEA-2017-0011-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl into Schedule I DEA-2017-0011 | Schedules of Controlled Substances: Temporary Placement of ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl into Schedule I | Proposed Rule | 2017-09-12T04:00:00Z | 2017 | 9 | 2017-09-12T14:11:38Z | 2017-19283 | 0 | 0 | 0900006482b28c4e | |||
| DEA-2017-0010-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of FUB-AMB Into Schedule I DEA-2017-0010 | Schedules of Controlled Substances: Temporary Placement of FUB-AMB into Schedule I | Proposed Rule | 2017-09-11T04:00:00Z | 2017 | 9 | 2017-09-11T18:59:42Z | 2017-17639 | 0 | 0 | 0900006482b23e2a | |||
| DEA-2017-0008-0001 | DEA | Schedules of Controlled Substances: Removal of Naldemedine from Control DEA-2017-0008 | Schedules of Controlled Substances: Removal of Naldemedine from Control | Proposed Rule | 2017-07-12T04:00:00Z | 2017 | 7 | 2017-07-12T04:00:00Z | 2017-08-12T03:59:59Z | 2017-08-11T01:02:14Z | 2017-14482 | 0 | 0 | 0900006482910c2c | |
| DEA-2017-0005-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of Acryl Fentanyl into Schedule I DEA-2017-0005 | Schedules of Controlled Substances: Temporary Placement of Acryl Fentanyl into Schedule I | Proposed Rule | 2017-06-02T04:00:00Z | 2017 | 6 | 2017-06-02T13:11:59Z | 2017-11215 | 0 | 0 | 090000648267f8ac | |||
| DEA-2017-0004-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I DEA-2017-0004 | Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I | Proposed Rule | 2017-03-23T04:00:00Z | 2017 | 3 | 2017-03-23T13:53:51Z | 2017-05728 | 0 | 0 | 090000648251fac5 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;